Ci Private Wealth, LLC Kura Oncology, Inc. Transaction History

Ci Private Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$5.55 - $6.92 $4,495 - $5,605	810 Added 6.22%	13,838 $79,000
Q1 2025 May 14, 2025	BUY	$6.6 - $9.05 $3,550 - $4,868	538 Added 4.31%	13,028 $85,000
Q4 2024 Feb 10, 2025	BUY	$8.51 - $19.21 $106,289 - $239,932	12,490 New	12,490 $108,000
Q4 2022 Feb 15, 2023	BUY	$11.23 - $16.9 $432,355 - $650,650	38,500 New	38,500 $477,000

214

81.2M

900K

228K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $749M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Ci Private Wealth, LLC with notifications on news.